Phraction Management LLC Acquires 7,296 Shares of Danaher Co. (NYSE:DHR)

Phraction Management LLC lifted its position in Danaher Co. (NYSE:DHR) by 24.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,993 shares of the conglomerate’s stock after acquiring an additional 7,296 shares during the quarter. Danaher accounts for approximately 3.5% of Phraction Management LLC’s investment portfolio, making the stock its 11th largest holding. Phraction Management LLC’s holdings in Danaher were worth $8,558,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Wellington Management Group LLP raised its holdings in shares of Danaher by 18.6% in the third quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate’s stock valued at $6,185,203,000 after acquiring an additional 3,905,449 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Danaher by 6.5% in the third quarter. Bank of New York Mellon Corp now owns 8,183,501 shares of the conglomerate’s stock valued at $2,030,327,000 after purchasing an additional 502,868 shares during the last quarter. Northern Trust Corp grew its stake in Danaher by 1.7% in the third quarter. Northern Trust Corp now owns 8,100,722 shares of the conglomerate’s stock valued at $2,009,789,000 after purchasing an additional 134,905 shares during the last quarter. Flossbach Von Storch AG grew its stake in Danaher by 1.8% in the fourth quarter. Flossbach Von Storch AG now owns 4,601,351 shares of the conglomerate’s stock valued at $1,064,477,000 after purchasing an additional 82,672 shares during the last quarter. Finally, Invesco Ltd. grew its stake in Danaher by 13.2% in the third quarter. Invesco Ltd. now owns 4,070,455 shares of the conglomerate’s stock valued at $1,009,880,000 after purchasing an additional 473,693 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Activity

In other news, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now owns 38,102 shares of the company’s stock, valued at $9,601,704. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Director Walter G. Lohr sold 3,289 shares of the company’s stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $251.15, for a total transaction of $826,032.35. Following the transaction, the director now owns 14,129 shares of the company’s stock, valued at $3,548,498.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Daniel Raskas sold 23,757 shares of the company’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now directly owns 38,102 shares in the company, valued at approximately $9,601,704. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 106,565 shares of company stock valued at $26,641,364. Company insiders own 10.90% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Raymond James boosted their price target on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. KeyCorp boosted their price target on Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. TD Cowen boosted their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Finally, Citigroup boosted their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $269.64.

Danaher Stock Down 0.3 %

DHR stock traded down $0.79 during trading on Wednesday, hitting $245.83. 800,611 shares of the company’s stock were exchanged, compared to its average volume of 2,761,143. The stock has a market capitalization of $182.08 billion, a price-to-earnings ratio of 41.81, a PEG ratio of 3.80 and a beta of 0.83. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $259.00. The business has a 50-day moving average price of $248.78 and a two-hundred day moving average price of $231.79. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm’s revenue was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.36 earnings per share. As a group, equities research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were issued a $0.27 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. This is a positive change from Danaher’s previous quarterly dividend of $0.24. Danaher’s payout ratio is presently 18.31%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.